Igarashi Motors India Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: November 8, 2025, 2:42 am

Competitors of Igarashi Motors India Ltd

All Competitor Stocks of Igarashi Motors India Ltd

Quarterly Result

Last Updated: August 20, 2025, 9:20 am

Below is a detailed analysis of the quarterly data for Igarashi Motors India Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 204.71 Cr.. The value appears strong and on an upward trend. It has increased from 189.47 Cr. (Mar 2025) to 204.71 Cr., marking an increase of 15.24 Cr..
• For Expenses, as of Jun 2025, the value is 185.10 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 169.76 Cr. (Mar 2025) to 185.10 Cr., marking an increase of 15.34 Cr..
• For Operating Profit, as of Jun 2025, the value is 19.61 Cr.. The value appears to be declining and may need further review. It has decreased from 19.71 Cr. (Mar 2025) to 19.61 Cr., marking a decrease of 0.10 Cr..
• For OPM %, as of Jun 2025, the value is 9.58%. The value appears to be declining and may need further review. It has decreased from 10.40% (Mar 2025) to 9.58%, marking a decrease of 0.82%.
• For Other Income, as of Jun 2025, the value is 0.80 Cr.. The value appears strong and on an upward trend. It has increased from 0.31 Cr. (Mar 2025) to 0.80 Cr., marking an increase of 0.49 Cr..
• For Interest, as of Jun 2025, the value is 3.17 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2.63 Cr. (Mar 2025) to 3.17 Cr., marking an increase of 0.54 Cr..
• For Depreciation, as of Jun 2025, the value is 13.87 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 13.39 Cr. (Mar 2025) to 13.87 Cr., marking an increase of 0.48 Cr..
• For Profit before tax, as of Jun 2025, the value is 3.37 Cr.. The value appears to be declining and may need further review. It has decreased from 4.00 Cr. (Mar 2025) to 3.37 Cr., marking a decrease of 0.63 Cr..
• For Tax %, as of Jun 2025, the value is 25.22%. The value appears to be increasing, which may not be favorable. It has increased from 23.50% (Mar 2025) to 25.22%, marking an increase of 1.72%.
• For Net Profit, as of Jun 2025, the value is 2.51 Cr.. The value appears to be declining and may need further review. It has decreased from 3.06 Cr. (Mar 2025) to 2.51 Cr., marking a decrease of 0.55 Cr..
• For EPS in Rs, as of Jun 2025, the value is 0.80. The value appears to be declining and may need further review. It has decreased from 0.97 (Mar 2025) to 0.80, marking a decrease of 0.17.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: October 15, 2025, 5:10 am

Growth

Last Updated: September 5, 2025, 6:50 am

Balance Sheet

Last Updated: November 9, 2025, 2:13 pm

Below is a detailed analysis of the balance sheet data for Igarashi Motors India Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:

• For Equity Capital, as of Sep 2025, the value is 31.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 31.00 Cr..
• For Reserves, as of Sep 2025, the value is 433.00 Cr.. The value appears to be declining and may need further review. It has decreased from 434.00 Cr. (Mar 2025) to 433.00 Cr., marking a decrease of 1.00 Cr..
• For Borrowings, as of Sep 2025, the value is 143.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 151.00 Cr. (Mar 2025) to 143.00 Cr., marking a decrease of 8.00 Cr..
• For Other Liabilities, as of Sep 2025, the value is 194.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 158.00 Cr. (Mar 2025) to 194.00 Cr., marking an increase of 36.00 Cr..
• For Total Liabilities, as of Sep 2025, the value is 802.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 775.00 Cr. (Mar 2025) to 802.00 Cr., marking an increase of 27.00 Cr..
• For Fixed Assets, as of Sep 2025, the value is 391.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 391.00 Cr..
• For CWIP, as of Sep 2025, the value is 61.00 Cr.. The value appears strong and on an upward trend. It has increased from 43.00 Cr. (Mar 2025) to 61.00 Cr., marking an increase of 18.00 Cr..
• For Investments, as of Sep 2025, the value is 1.00 Cr.. The value appears to be declining and may need further review. It has decreased from 17.00 Cr. (Mar 2025) to 1.00 Cr., marking a decrease of 16.00 Cr..
• For Other Assets, as of Sep 2025, the value is 349.00 Cr.. The value appears strong and on an upward trend. It has increased from 323.00 Cr. (Mar 2025) to 349.00 Cr., marking an increase of 26.00 Cr..
• For Total Assets, as of Sep 2025, the value is 802.00 Cr.. The value appears strong and on an upward trend. It has increased from 775.00 Cr. (Mar 2025) to 802.00 Cr., marking an increase of 27.00 Cr..

Notably, the Reserves (433.00 Cr.) exceed the Borrowings (143.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Igarashi Motors India Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 7.68. This value is within the healthy range. It has increased from 3.04 (Mar 24) to 7.68, marking an increase of 4.64.
• For Diluted EPS (Rs.), as of Mar 25, the value is 7.68. This value is within the healthy range. It has increased from 3.04 (Mar 24) to 7.68, marking an increase of 4.64.
• For Cash EPS (Rs.), as of Mar 25, the value is 24.05. This value is within the healthy range. It has increased from 18.64 (Mar 24) to 24.05, marking an increase of 5.41.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 147.91. It has increased from 142.01 (Mar 24) to 147.91, marking an increase of 5.90.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 147.91. It has increased from 142.01 (Mar 24) to 147.91, marking an increase of 5.90.
• For Dividend / Share (Rs.), as of Mar 25, the value is 2.50. This value is within the healthy range. It has increased from 1.00 (Mar 24) to 2.50, marking an increase of 1.50.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 266.38. It has increased from 230.35 (Mar 24) to 266.38, marking an increase of 36.03.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 30.95. This value is within the healthy range. It has increased from 24.05 (Mar 24) to 30.95, marking an increase of 6.90.
• For PBIT / Share (Rs.), as of Mar 25, the value is 14.58. This value is within the healthy range. It has increased from 8.46 (Mar 24) to 14.58, marking an increase of 6.12.
• For PBT / Share (Rs.), as of Mar 25, the value is 10.33. This value is within the healthy range. It has increased from 4.41 (Mar 24) to 10.33, marking an increase of 5.92.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 7.68. This value is within the healthy range. It has increased from 3.04 (Mar 24) to 7.68, marking an increase of 4.64.
• For PBDIT Margin (%), as of Mar 25, the value is 11.62. This value is within the healthy range. It has increased from 10.44 (Mar 24) to 11.62, marking an increase of 1.18.
• For PBIT Margin (%), as of Mar 25, the value is 5.47. This value is below the healthy minimum of 10. It has increased from 3.67 (Mar 24) to 5.47, marking an increase of 1.80.
• For PBT Margin (%), as of Mar 25, the value is 3.87. This value is below the healthy minimum of 10. It has increased from 1.91 (Mar 24) to 3.87, marking an increase of 1.96.
• For Net Profit Margin (%), as of Mar 25, the value is 2.88. This value is below the healthy minimum of 5. It has increased from 1.32 (Mar 24) to 2.88, marking an increase of 1.56.
• For Return on Networth / Equity (%), as of Mar 25, the value is 5.19. This value is below the healthy minimum of 15. It has increased from 2.14 (Mar 24) to 5.19, marking an increase of 3.05.
• For Return on Capital Employeed (%), as of Mar 25, the value is 8.99. This value is below the healthy minimum of 10. It has increased from 5.24 (Mar 24) to 8.99, marking an increase of 3.75.
• For Return On Assets (%), as of Mar 25, the value is 3.11. This value is below the healthy minimum of 5. It has increased from 1.23 (Mar 24) to 3.11, marking an increase of 1.88.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.02. This value is below the healthy minimum of 0.2. It has decreased from 0.04 (Mar 24) to 0.02, marking a decrease of 0.02.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.27. This value is within the healthy range. It has increased from 0.25 (Mar 24) to 0.27, marking an increase of 0.02.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 1.08. It has increased from 0.96 (Mar 24) to 1.08, marking an increase of 0.12.
• For Current Ratio (X), as of Mar 25, the value is 1.24. This value is below the healthy minimum of 1.5. It has decreased from 1.37 (Mar 24) to 1.24, marking a decrease of 0.13.
• For Quick Ratio (X), as of Mar 25, the value is 0.81. This value is below the healthy minimum of 1. It has decreased from 0.94 (Mar 24) to 0.81, marking a decrease of 0.13.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 7.48. This value is within the healthy range. It has increased from 4.37 (Mar 24) to 7.48, marking an increase of 3.11.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 13.02. This value is below the healthy minimum of 20. It has decreased from 32.87 (Mar 24) to 13.02, marking a decrease of 19.85.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 4.15. This value is below the healthy minimum of 20. It has decreased from 5.36 (Mar 24) to 4.15, marking a decrease of 1.21.
• For Earning Retention Ratio (%), as of Mar 25, the value is 86.98. This value exceeds the healthy maximum of 70. It has increased from 67.13 (Mar 24) to 86.98, marking an increase of 19.85.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 95.85. This value exceeds the healthy maximum of 70. It has increased from 94.64 (Mar 24) to 95.85, marking an increase of 1.21.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 7.28. This value is within the healthy range. It has increased from 5.94 (Mar 24) to 7.28, marking an increase of 1.34.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 2.81. This value is below the healthy minimum of 3. It has increased from 1.75 (Mar 24) to 2.81, marking an increase of 1.06.
• For Enterprise Value (Cr.), as of Mar 25, the value is 1,681.46. It has increased from 1,399.67 (Mar 24) to 1,681.46, marking an increase of 281.79.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 2.01. This value is within the healthy range. It has increased from 1.93 (Mar 24) to 2.01, marking an increase of 0.08.
• For EV / EBITDA (X), as of Mar 25, the value is 17.26. This value exceeds the healthy maximum of 15. It has decreased from 18.49 (Mar 24) to 17.26, marking a decrease of 1.23.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.86. This value is within the healthy range. It has increased from 1.78 (Mar 24) to 1.86, marking an increase of 0.08.
• For Retention Ratios (%), as of Mar 25, the value is 86.97. This value exceeds the healthy maximum of 70. It has increased from 67.12 (Mar 24) to 86.97, marking an increase of 19.85.
• For Price / BV (X), as of Mar 25, the value is 3.34. This value exceeds the healthy maximum of 3. It has increased from 2.89 (Mar 24) to 3.34, marking an increase of 0.45.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.86. This value is within the healthy range. It has increased from 1.78 (Mar 24) to 1.86, marking an increase of 0.08.
• For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness